The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

B•••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Also written as: Inc. and
Principal held
at least $53.7M
sum of BDC pieces, a lower bound
Fair value
$56.2M
102c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 1, 2028
no dated debt inside 24 months
On the tape since
Sep 30, 2023
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $53.7M102cS+300 bp
PIK 0.25%
Oct 1, 20281
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, O•••••• 2028, P•••• + 3.00%, F•••• rate 10.50%, PIK I••••••• 0.25%, 5.45%
$53.7M$56.2M
102c
S+300 bp
PIK 0.25%
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$53.7M$56.2M102c1
Mar 31, 20261$53.7M$55.7M102c1
Dec 31, 20251$107M$111M102c2
Sep 30, 20251$53.6M$55.6M102c1
Jun 30, 20251$53.5M$55.5M103c1
Mar 31, 20251$53.3M$55.4M103c1
Dec 31, 20241$106M$111M104c2
Sep 30, 20241$53.0M$54.5M103c1
Jun 30, 20241$52.9M$54.9M104c1
Mar 31, 20241$52.7M$53.5M102c1
Dec 31, 20231$158M$157M100c3
Sep 30, 20231$52.5M$51.9M100c1
What changed
Every change including routine ones
Identity
Group key
BRAEBURNderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it